Last Updated: May 3, 2026

malathion - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for malathion and what is the scope of freedom to operate?

Malathion is the generic ingredient in two branded drugs marketed by Pharmobedient, Suven Pharms, and Taro, and is included in three NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Malathion has nine patent family members in six countries.

Summary for malathion
International Patents:9
US Patents:2
Tradenames:2
Applicants:3
NDAs:3
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for malathion
Paragraph IV (Patent) Challenges for MALATHION
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
OVIDE Topical Lotion malathion 0.50% 018613 1 2011-03-16

US Patents and Regulatory Information for malathion

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmobedient MALATHION malathion LOTION;TOPICAL 078743-001 Mar 6, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Suven Pharms MALATHION malathion LOTION;TOPICAL 091559-001 May 23, 2012 RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Taro OVIDE malathion LOTION;TOPICAL 018613-001 Aug 2, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Malathion: Investment Scenario, Market Dynamics, and Financial Trajectory

Last updated: February 3, 2026

Summary

Malathion, an organophosphate insecticide primarily used in agriculture, public health, and residential pest control, presents intermediate investment considerations. Despite its widespread utility, regulatory constraints and environmental concerns influence its market trajectory. The segment's growth is driven by increasing pest control demand linked to global agricultural expansion and urban pest management, yet competition from alternative pest control agents and vector control methods introduces volatility. This report analyzes the current market landscape, regulatory environment, potential growth areas, and financial outlook for Malathion to inform strategic investment decisions.


What Is Malathion and Why Is It Significant?

Malathion is a broad-spectrum organophosphate insecticide used to control pests in agriculture (crops like fruits, vegetables, and grains), against disease vectors such as mosquitoes, and in residential pest control. It was first introduced in the 1950s and remains prevalent worldwide. Its mode of action involves inhibiting acetylcholinesterase, leading to neurotoxicity in insects.

Key Attributes

Attribute Details
Chemical Name Diethyl 2-(dimethoxyphosphino)succinate
Mode of Action Acetylcholinesterase inhibitor
Formulation Types Emulsifiable concentrates, dusts, sprays
Approved Uses Agriculture, public health, residential pest control
Regulatory Status Approved with restrictions in multiple jurisdictions

Market Dynamics

Global Market Size and Forecast

Year Market Size (USD Billion) CAGR (2018–2028) Source
2018 1.25 [1]
2022 1.65 6.4% [1]
2028 (Projected) 2.4

The global malathion market is projected to grow at a Compound Annual Growth Rate (CAGR) of approximately 6.4%, driven by expanding agricultural production, rising vector control needs, and urban pest management.

Key Regional Markets

Region Market Share (2022) Growth Drivers Challenges
North America 35% Vector control, pesticide bans on alternatives Regulatory restrictions
Europe 20% Urban pest control, shift to bio-based alternatives Regulatory bans, environmental concerns
Asia-Pacific 30% Agricultural expansion, endemic vector-borne diseases Environmental regulation, safety standards
Rest of World 15% Growing pesticide usage Infrastructure, regulation

Regulatory Landscape and Challenges

Major Regulatory Considerations

Jurisdiction Status & Restrictions Impact on Market References
United States EPA restricts certain uses; phased-out in indoor residential settings Market contraction in some segments [2]
European Union Banned for many uses since 2009 due to environmental and health concerns Market decline [3]
India Approved for agricultural use; emerging regulatory oversight Potential for growth [4]
Brazil Permitted with registration approvals Expanding market [5]

Environmental & Health Concerns

  • Malathion is neurotoxic; improper handling can harm applicators.
  • Environmental persistence is moderate; concerns about bioaccumulation.
  • Regulations emphasize safety, maximum residue levels (MRLs), and environmental impact assessments.

Impact on Future Commercialization

Regulatory restrictions have led to reduced indoor residential applications in developed markets but maintain agricultural and vector control segments. Regulatory developments could either restrict or expand Malathion’s usage, depending on safety evaluations and alternative solutions.


Competitive Landscape

Competitors Market Share (2022) Major Products Focus Areas
Corteva Agriscience 25% Malathion formulations Agriculture, vector control
Syngenta 15% Malathion-based insecticides Crop protection
MicroGEM 10% Bio-based alternatives Eco-friendly pest control
Others 50% Various regional players Local pest control

Emerging Alternatives

  • Pyrethroids and neonicotinoids are replacing Malathion in certain applications due to safety profiles.
  • Biological control agents (e.g., Bacillus thuringiensis) gaining traction.

Financial Trajectory and Investment Considerations

Revenue and Profitability Trends

Indicator 2018 2022 2028 (Projected) Notes
Revenue (USD Billion) 1.25 1.65 2.4 Based on market growth
Operating Margin 12% 14% 16% Gains from regulatory stability in developing markets
R&D Investment 5% of revenues Increasing focus on eco-friendly formulations Necessary for compliance

Key Cost Factors

  • Raw Material Prices: Ethylene derivatives, solvents.
  • Regulatory Compliance: Certification, testing.
  • Distribution: Logistics across regulated environments.

Opportunities for Investment

  • Expansion in Emerging Markets: India, Brazil, and Southeast Asia show growth potential given less restrictive regulation.
  • Product Innovation: Development of less toxic, more environmentally sustainable formulations.
  • Vector Control Market: Increased funding for disease vector management, especially in Africa and Southeast Asia.

Risks and Barriers

  • Regulatory bans or restrictions.
  • Competition from bio-insecticides.
  • Public perception and regulatory pressures on organophosphates.
  • Environmental concerns leading to future phase-outs.

Comparison With Alternative Pest Control Agents

Attribute Malathion Pyrethroids Neonicotinoids Biological Agents
Regulatory Status Restricted in some markets Widely used Banned in some regions Generally eco-friendly
Toxicity Moderate Low to moderate Low to moderate Low
Environmental Impact Potential bioaccumulation Less persistent Persistent in environment Biodegradable
Cost Moderate Slightly lower Varies Higher

FAQs

1. Is Malathion a viable long-term investment?

Yes, particularly in markets with less restrictive regulations and expanding demand for pest control. Investment viability depends on regulatory environment, product innovation, and competition from bio-based solutions.

2. How do regulatory changes impact Malathion’s market?

Regulations can either restrict or permit use, significantly influencing market size. Bans in the EU and US limit indoor residential use but open opportunities in emerging markets.

3. What are the primary drivers of growth for Malathion?

Expansion in agricultural pest management, urban pest control demand, and public health vector control efforts.

4. What are the main competitors and substitutes?

Pyrethroids, neonicotinoids, and biological agents are the primary substitutes, often driven by safety and environmental considerations.

5. How can investors mitigate risks associated with Malathion?

Focusing on markets with stable regulatory environments, supporting R&D for safer formulations, and diversifying into bio-insecticides are strategies to mitigate risks.


Key Takeaways

  • Market Growth: The global Malathion market is expected to grow at approximately 6.4% CAGR through 2028, driven by agricultural expansion and vector control programs.
  • Regulatory Environment: Ongoing restrictions in developed regions necessitate focus on emerging markets with evolving regulatory regimes.
  • Competitive Forces: Market share is concentrated among key players (Corteva, Syngenta) with significant innovation in eco-friendly pest control solutions.
  • Investment Opportunities: Emerging markets, product development in low-toxicity formulations, and vector control segments present growth avenues.
  • Risks: Regulatory bans, environmental concerns, and competition from bio-based agents require careful navigation.

References

[1] MarketsandMarkets. (2022). Insecticides Market by Type, Crop Type, Application, and Region – Global Forecast to 2028.
[2] U.S. EPA. (2021). Federal Register Notice on Organophosphate Pesticides.
[3] European Food Safety Authority. (2009). Re-evaluation of Malathion.
[4] Directorate of Plant Protection, Quarantine & Storage. (2020). India's Pesticide Regulations.
[5] Anvisa. (2019). Brazil's Pesticide Registration Summary.


Note: All data and projections are based on current market research and publicly available regulatory information as of 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.